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Abstract
Plasmodium falciparum sporozoites that develop and mature inside an Anopheles mosquito initiate a malaria infection in
humans. Here we report the first proteomic comparison of different parasite stages from the mosquito—early and late
oocysts containing midgut sporozoites, and the mature, infectious salivary gland sporozoites. Despite the morphological
similarity between midgut and salivary gland sporozoites, their proteomes are markedly different, in agreement with their
increase in hepatocyte infectivity. The different sporozoite proteomes contain a large number of stage specific proteins
whose annotation suggest an involvement in sporozoite maturation, motility, infection of the human host and associated
metabolic adjustments. Analyses of proteins identified in the P. falciparum sporozoite proteomes by orthologous gene
disruption in the rodent malaria parasite, P. berghei, revealed three previously uncharacterized Plasmodium proteins that
appear to be essential for sporozoite development at distinct points of maturation in the mosquito. This study sheds light
on the development and maturation of the malaria parasite in an Anopheles mosquito and also identifies proteins that may
be essential for sporozoite infectivity to humans.
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Introduction
The life cycle of human malaria parasite Plasmodium falciparum
within the mosquito vector begins when gametocytes are taken up
in an infected blood meal; after forming gametes and fertilisation,
the resulting zygote differentiates into a motile ookinete that
traverses the midgut epithelium and transforms within 36–
48 hours into an oocyst (OOC) between the midgut epithelial
cells and the basal lamina. The oocyst is an asexually replicating
form of the parasite, which produces up to 2000–4000 sporozoites
in about two weeks. Rupture of mature oocysts releases oocyst-
derived sporozoites (ODS) into the hemocoel of the mosquito. The
movement of the hemolymph brings the ODS in contact with the
salivary glands, which they then invade. The sporozoites mature
inside the salivary glands and then are stored ready for
transmission to the mammalian host upon the next blood meal.
A limited number of the salivary gland sporozoites (SGS) are
injected during a mosquito bite and only a few of these complete
the necessary migration from the skin to the liver to establish an
infection inside hepatocytes. Clearly, the sporozoite has to
complete a number of functions and metabolic readjustments
both before and after injection into a mammalian host. The
sporozoite has to be capable of actively exiting an oocyst, travelling
through the hemolymph (the mosquito circulatory system), and
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invading salivary glands. Further, following a mosquito bite
injection the sporozoites enters a very different physiological
environment of the human host, and then has to traverse through
human endothelial cells, possibly Kupffer cells and finally
hepatocytes where they establish an infection; moving all the time
using a specialized form of gliding motility. Despite all these events
the general morphology of the sporozoite is not visibly altered at
any stage (for general reviews on sporozoite biology please see the
following references and the references therein [1–7]).
Since the sporozoite plays an essential role in the first phase of a
malaria infection, an understanding of its biology is of great
importance in order to develop intervention methods against
initial infection and consequently disease. A wealth of gene
expression data from high throughput studies exists on the
intracellular erythrocytic growth and development of Plasmodium
parasites [8–17], whereas far less is known about the genes/
proteins involved in sporozoite development [10,11,16,18–22].
Indeed, only a few (less than 25) proteins have been characterized
as being essential for sporozoite development and infectivity.
These include several proteins that are currently under investiga-
tion as either potential subunit vaccines (such as circumsporozoite
protein (CS) and thrombospondin related anonymous protein
(TRAP)) or may serve in the generation of whole organism,
genetically attenuated sporozoite vaccines [23–26] when the genes
encoding these proteins are eliminated from the Plasmodium
genome, such as UIS3, UIS4 [27,28] and P36 and P36p
[29,30]. The lack of large scale in vitro culture methods for oocysts
and sporozoites has restricted high throughput protein expression
studies to only mature sporozoites, which are more readily
obtained from infected salivary glands.
In this study we have performed a detailed proteomic
comparison of sporozoites obtained from both oocysts and salivary
glands which were obtained by hand-dissection of infected
mosquito midguts and salivary glands. The proteome analysis
was performed using essentially the same high throughput mass
spectrometric analysis that we previously applied to generate the
proteomes of the blood stages of P. falciparum [15] as well as the
proteomes of male and female gametocytes of P. berghei [14]. Our
analyses resulted in a proteome of oocysts (n = 127), oocyst-derived
sporozoites (n = 450) and salivary gland sporozoites (n = 477),
which represent 728 individual Plasmodium proteins, of which 250
were exclusively detected in the oocyst/sporozoite stages when
compared to the P. falciparum blood stage proteomes generated in a
previous study [15]. The identification of proteins and their
relative distributions within the different proteomes suggest specific
metabolic adaptations and other biological functions of the
maturing sporozoite. Moreover, we analyzed the function of eight
sporozoite-specific proteins identified in our proteome analyses
that were specifically annotated as hypothetical proteins, by
targeted gene disruption of the orthologous genes of the rodent
malaria parasite, P. berghei. We were able to demonstrate an
essential and distinct role for three of these proteins in sporozoite
development.
Results
Mosquito stage proteome
Protein samples derived from infected mosquito midguts and
salivary glands were analyzed by nano–liquid chromatography
tandem mass spectrometry (nLC-MS/MS) essentially as previously
described [15]. The MS/MS spectra were searched against a
combined database of all possible predicted tryptic peptides derived
from all P. falciparum, human, and mosquito (Anopheles gambiae)
proteins. The proteomic analysis of P. falciparum oocysts, oocyst-
derived sporozoites, and salivary gland sporozoites resulted in a total
of 4611 unique peptides mapping to 728 non redundant P. falciparum
proteins; they are distributed over the three stages with 127, 450 and
477, respectively and depicted as a Venn diagram in Figure 1A.
Identified tryptic peptides and corresponding Plasmodium proteins of
the mosquito stages are provided as supplementary material (Table
S1). In our previous analysis of infected human red blood cells we
identified 741 asexual blood stage parasite proteins from a mixture of
schizonts and trophozoites and an additional 931 gametocyte and
645 gamete proteins [15]. Merging these datasets with the proteomes
of the mosquito stages resulted in the identification of 250 Plasmodium
proteins (Table S1) that are specifically detected in mosquito stages
and 809 proteins that are expressed only in the blood stages
(Figure 1B). However, it is important to note that due to the
incomplete nature of all proteome datasets, absence of proteins from
one dataset may also be due to the limits of detection and not the
actual absence of expression. Parasite samples derived from infected
mosquitoes were considerably contaminated with mosquito proteins
with total parasite protein fractions of 35% for ODS, 31% for SGS
and for OOC only 11% of the sequenced proteins were parasite in
origin. Therefore this relatively high degree of contamination
resulted in overall lower numbers of proteins compared to our
previous Plasmodium infected blood stage proteome study. In
particular, only 127 P. falciparum proteins in a pool of 987 mosquito
proteins were identified for the oocyst sample that presumably
represents the more abundantly expressed parasite proteins.
Therefore, further analysis of the identified proteins and additional
functional analyses are mainly focused on the proteins identified in
the ODS and SGS. In total, we analyzed six different stages of
Plasmodium (both from this study and our previous work) and have
identified a total of 1543 Plasmodium proteins. The proportion of
‘stage specific’ proteins in the different life cycle stages ranged from
12% (gametes) to 28% and the stage specificity of proteins in the
mosquito stages ranged between 15–24% (Figure 1C).
Comparison with existing RNA/protein mosquito stage
studies
Genome-wide proteome and transcriptome studies have
previously been reported for salivary gland sporozoites of P.
falciparum [10,16], for oocysts and sporozoites of P. berghei [11] and
Author Summary
Human malaria is caused by Plasmodium falciparum, a
unicellular protozoan parasite that is transmitted by
Anopheles mosquitoes. An infectious mosquito injects saliva
containing sporozoite forms of the parasite and these then
migrate from the skin to the liver, where they establish an
infection. Many intervention strategies are currently focused
on preventing the establishment of infection by sporozoites.
Clearly, an understanding of the biology of the sporozoite is
essential for developing new intervention strategies. Sporo-
zoites are produced within the oocyst, located on the
outside wall of the mosquito midgut, and migrate after
release from the oocysts to the salivary glands where they
are stored as mature infectious forms. Comparison of the
proteomes of sporozoites derived from either the oocyst or
from the salivary gland reveals remarkable differences in the
protein content of these stages despite their similar
morphology. The changes in protein content reflect the
very specific preparations the sporozoites make in order to
establish an infection of the liver. Analysis of the function of
several previously uncharacterized, conserved proteins
revealed proteins essential for sporozoite development at
distinct points of their maturation.
Proteomics of P. falciparum Sporozoite Maturation
PLoS Pathogens | www.plospathogens.org 2 October 2008 | Volume 4 | Issue 10 | e1000195
recently for oocyst-derived sporozoites and salivary gland
sporozoites of P.yoelii [22]. The Florens et al SGS proteome [10]
identified a total of 1048 proteins of which 314 proteins include at
least one peptide that is fully tryptic. It has been shown that
selection of only fully tryptic peptides greatly increases the
confidence in each protein within the proteome and was similarly
applied to our dataset [31]. Comparison of these ‘fully-tryptic
proteins’ (proteins identified by peptides conforming to proper
tryptic cleavage) with the ‘fully-tryptic proteins’ from our SGS
proteome (n = 477) shows that 166 proteins are present in both
proteomes (i.e. 53% of the Florens’ data (Table S2)). Moreover, in
order to further increase our confidence in the ‘protein-calling’ in
both datasets, a comparison was made using only those proteins
that were identified by 2 or more fully-tryptic peptides (i.e. 346
proteins from our mosquito stage proteome and 82 from the
Florens SGS proteome). In this analysis, we found that 72 proteins
were in common (i.e. 88% of the Florens enriched SGS proteome).
Interestingly, we fail to find any PfEMP-1 proteins, as had
previously been reported in the Florens et al SGS proteome, in
either dataset when we examine only the ‘‘fully-tryptic peptide
proteomes’’ [10].
The oocyst proteome of P. berghei described by Hall et al [11]
detected of a total of 220 proteins of which 175 proteins have an
orthologue in P. falciparum and 87 of these (i.e. 50%) were also
detected in our mosquito proteomes (Table S2). Again consider-
ation of only fully tryptic peptides revealed that 60 of the resulting
111 P. berghei orthologs (i.e. 54%) were found in common.
Similarly, of the 108 proteins identified in the P. berghei SGS
proteome 86 proteins have an orthologue in P. falciparum (Table
S2) of which 46 (i.e. 53% of the Hall SGS proteome) were detected
in our SGS proteome of P. falciparum. There were only 20 fully-
tryptic proteins in the Hall SGS proteome of which 75% (n = 15)
were also detected in our P. falciparum SGS proteome. Selecting the
202 genes that were commonly expressed in our SGS proteome
and in the published SGS proteome of P. falciparum [10], the
relative abundance of protein in the two datasets was examined
using a Pearson correlation. The emPAI peptide counting method
using the number of observed peptides detected per protein and
corrected to the number of expected tryptic peptides was applied
to compute relative protein levels [32,33]. A good correlation
(r = 0.73) existed between protein abundance levels (emPAI values;
see Materials and Methods section) in our SGS proteome and the
previous P. falciparum SGS proteome.
However, when we compared abundance of our SGS proteins
(i.e. by emPAI values) with the abundance of mRNA SGS
transcripts reported by Le Roch and Zhou et al [16,22] we found a
lower correlation value (i.e. 0.31 and 0.33 respectively (Table S3)).
Several (smaller scale) studies have been reported that using
either subtractive hybridization or cDNA quantification methods
(i.e. Serial Analysis of Gene Expression (SAGE)) to identify sets of
genes transcribed in sporozoites in the rodent malaria parasites, P.
berghei [20,21] and P. yoelii [18]. Comparison of the identified P.
yoelii mRNAs with our proteomes showed that for nearly all genes
transcribed in sporozoites (20 out of 23 sporozoite (S) genes),
proteins were detected in our sporozoite proteomes (Table S4).
This may suggest that for a significant proportion of genes
transcription and protein expression coincide within the sporozo-
ite. However, a weaker correlation was found between transcrip-
tion in P. berghei sporozoites and the presence of protein in our
proteomes. Specifically, we were able to detect protein for 34 of
the 98 genes identified in the P. berghei sporozoites SAGE analysis
(i.e. the Sporozoite expressed gene Identified by SAGE (SIS) genes
(Table S4)) but only 5 out of 26 transcribed genes in the
Suppression Subtractive Hybridization (SSH) analysis (i.e. the
Figure 1. Distribution of identified P. falciparum proteins over
different life-cycle stages. (A) Venn diagram depicting the
distribution of detected P. falciparum proteins over three different
mosquito life-cycle stages (oocysts, oocyst-derived sporozoites and
salivary gland sporozoites). Numbers represent the number of proteins,
that are either shared between 2 or 3 stages (overlapping areas) or that
are detected in a single stage. (B) Comparison of the expression of P.
falciparum proteins detected in the three mosquito stage proteomes to
the blood stage proteomes described previously [15]. (C) The
percentage of proteins exclusively detected in only one proteome
out of 6 different life cycle stage proteomes, i.e. ASX - asexual blood
stages; GCT – gametocytes; GAM – gametes; OOC – oocysts; ODS -
oocyst-derived sporozoites; SGS - salivary gland sporozoites.
doi:10.1371/journal.ppat.1000195.g001
Proteomics of P. falciparum Sporozoite Maturation
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Upregulated In Sporozoites (UIS) genes (Table S4)). It is however
interesting to observe that between the two SSH studies only 2 out
of 30 genes appear clearly up-regulated in both P. yoelii and P.
berghei sporozoites.
Functional annotation of mosquito stage proteins
A global functional characterization of the ‘mosquito stage’
proteome was performed by an enrichment analysis of Gene
Ontology (GO) annotations, for both the proteins that are shared
between blood stages and mosquito stages (n = 478) and for the
mosquito stage specific proteins (n = 250). The set of 478 genes
commonly expressed in both mosquito and blood stages showed
enrichment in GO annotations in all classes (i.e. Molecular
Function, Cellular Component and Biological process (Figure S1))
and this enrichment is principally associated with housekeeping
genes (Figure 2). The mosquito stage specific proteome did not
reveal significant (p,0.01) enrichment in GO annotations nor did
additional analyses for GO enrichment of the mosquito stage
specific proteins using BINGO [34] and Ontologizer [35] (data
not shown). In Figure 2B GO categories (Molecular Function) are
shown for the mosquito stage specific proteome that contain more
than 5 proteins. The lack of enrichment could be caused by the
high proportion of genes annotated as hypothetical (300 out of
728) and consequently the relatively large number of proteins in
the mosquito stage specific proteome (124 out of 250) without a
GO annotation. Since our analysis did not reveal a significant GO
enrichment for proteins known to be important in sporozoite
function (e.g. motility and motor activity (Figure 2)) we analyzed
our mosquito stage proteome for previously reported proteins, for
which a function during sporozoite development is described and
supported by strong experimental evidence (e.g. gene-knockout
and/or antibody-inhibition studies). These proteins, in total 23,
are listed in Table 1 and 15 out of 23 proteins are present in the
mosquito stage proteome reported here. Based on a total number
of 5410 genes in the genome of P. falciparum and 728 proteins in
our mosquito stage proteome, these 15 proteins represent a 4.8
fold functional enrichment relative to the annotated genome and is
highly significant (p,0.001 using Ontologizer). A good agreement
exists between the function of the sporozoite proteins as shown in
Table 1 and their expression pattern in the different mosquito
stages. For example, proteins with multiple roles during sporozoite
maturation (e.g. CS and TRAP) were identified in all stages
(OOC, ODS and SGS) whereas proteins involved in hepatocyte
traversal, such as SPECT1, SPECT2 (sporozoite microneme
protein essential for cell traversal 1 and 2) and CelTOS (cell-
traversal protein for ookinetes and sporozoites) were exclusively
identified in mature SGS.
Sporozoites, like other motile stages (except male gametes) of
Apicomplexan organisms, move on substrates by a mechanism
known as gliding motility which is driven by an actomyosin motor
complex [3,36,37]. Although there was no enrichment with high
confidence (p,0.05) of the GO Molecular Function category
‘motor activity’ for mosquito stage specific proteins (Figure 2),
several proteins known to be involved in the actomyosin motor
complex are well represented and include TRAP, myosin A,
MyoA Tail Domain Interacting Protein (MTIP), actin and F-1,6-
BP aldolase (3.6 fold enrichment with low confidence). Addition-
ally, sporozoites encode a variety of surface molecules for both
motility and invasion of host cells. For apicomplexan parasites
members of the TRAP/MIC2 family have been shown to be
important for host cell recognition and motility. The general
architecture of this family is typified by one or more thrombos-
pondin type I (TSP1) domains in their extracellular regions which
may in addition also posses von Willebrand factor A (vWA)
extracellular domains [38]. Our sporozoite proteome shows a 4.7
fold enrichment for proteins that contain one or multiple TSP1
domains (Table 2) compared to the P. falciparum proteome of 5410
proteins.
Two sporozoite proteomes – ODS versus SGS
Although the morphology of oocyst-derived and salivary gland
sporozoites is identical at the level of light microscopy, ODS of P.
berghei are significantly less infective to the mammalian host than
SGS [39]. This marked difference in infectivity suggests significant
developmental changes between these forms and was indicated by
the analyses of gene transcription of different sporozoite stages by
either SSH screens or SAGE analysis, which alludes to changes in
protein expression in the sporozoite during the period of egress
from the oocysts and the establishment of infection of the salivary
glands [18,20,21]. In agreement with these observations, we found
a large number of proteins expressed in SGS that were absent or
relatively low expressed in ODS (Table S1). Several proteins
involved in metabolic pathways show clear differences in
distribution between ODS and SGS (Figure S2). For example, 8
out of 9 enzymes of the glycolytic pathway for ATP production
were detected, all which were either more abundant or exclusive to
SGS (SGS 8 proteins with 140 peptides; ODS 4 proteins and 48
peptides). A similar profile is observed for proteins involved in the
production of NADPH via the pentose phosphate pathway with an
up-regulation of these proteins in SGS (5 proteins and 26 peptides)
compared to ODS (1 protein and 2 peptides). A third up-regulated
metabolic pathway is the tricarboxylic acid (TCA) cycle (7 proteins
and 85 peptides in SGS compared to 4 proteins and 26 peptides in
ODS). Interestingly, several genes (4 out of 10) of the TCA cycle
are most abundantly expressed in SGS, not only when compared
to ODS but also in comparison with the blood stages, indicating
an important role of the TCA cycle in mature sporozoites. Also the
enzyme phosphoenolpyruvate carboxykinase (PF13_0234) is
upregulated in the salivary gland sporozoites (8 peptides in ODS
and 17 in SGS), which is again in agreement with the upregulation
of enzymes involved in the TCA cycle and glycolysis [40]. It also
appears that SGS prepare for enhanced protein synthesis: 9 of the
11 detected tRNA ligases are only detected in the SGS proteome
and not in the ODS proteome (Table S1) as are ribosomal
proteins, translation elongation factors and the TCP chaperonin
complex proteins, which are either exclusively detected in SGS or
are represented in the SGS proteome by substantially more
peptides compared to the ODS proteome. As is shown in Table 1,
proteins that are known to play a role in traversal and invasion of
hepatocytes are highly enriched in SGS. On the other hand, the
expression of MAEBL that is expressed along with CS and well
before AMA-1 [41] and is known to function in attachment and
invasion of the salivary gland [42] is more abundantly expressed in
ODS. Therefore, it would appear that the proteomes of the
sporozoite characterised by this study at different stages of
development accurately reflect the functionality of either the
ODS or SGS.
Consequently, based on the expression pattern and relative
abundance of the peptides in the proteomes from OOC, ODS and
SGS (see Materials and Methods section) the mosquito stage
specific proteins can be regarded as belonging to one of 3 distinct
groups (Table S1): Group I consists of 112 ODS proteins highly
enriched for the ODS stage, putatively involved in sporozoite
maturation inside the oocyst and in salivary gland invasion;
similarly Group II which contains 74 proteins up-regulated in SGS
potentially involved in infection of the mammalian host; and
finally Group III that contains 59 proteins that are shared between
the different mosquito stage proteomes and therefore may be
Proteomics of P. falciparum Sporozoite Maturation
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involved in sporozoite functions necessary both in the mosquito
vector and the mammalian host (e.g. proteins involved in gliding
motility and invasion such as CS [43,44] and TRAP [45,46]
(Table 1)). These three groups formed the basis for selection of
genes for further functional analysis of their encoded proteins
through targeted disruption of the orthologous genes in the rodent
malaria parasite, P. berghei. The three groups were further refined
for subsequent functional analysis using the following criteria (see
also Materials and Methods section): i) high expression level as
determined by the number of uniquely detected peptides per
protein, ii) presence of gene sequences encoding putative
transmembrane regions, signal peptides and/or GPI anchors,
and iii) presence exclusively in the mosquito stage proteomes. This
resulted in selection of genes as shown in Table 3. Further, in
order to enrich for proteins that may define Plasmodium specific
functions, we preferentially selected not only genes that were
annotated as hypothetical but also had no domains predicted by
either the SMART or Pfam algorithms (i.e. with no indication of
predicted function).
Functional characterization of sporozoites-specific
proteins
In total eight genes identified in this study were selected (Table 4)
for functional analysis by targeted gene disruption of their
corresponding orthologs in P. berghei, specifically, 3 ODS specific
Figure 2. Gene Ontology term enrichment analysis of mosquito stage proteome. (A) Enrichment for GO ‘Biological Process’ terms of
proteins detected in mosquito and blood stages. The figure shows terms on the x-axis that are significantly enriched (p,0.004) by more than four
fold. GO terms of the shared set of proteins (n = 478, purple bars) is compared to terms of all predicted P. falciparum proteins (5410, green bars). The
y-axis displays the fraction relative to all GO Biological Process terms. (B) Enrichment for GO ‘Molecular Function’ main terms of proteins detected
specifically in mosquito stages (and blood stages). GO terms of the mosquito specific set of proteins (n = 250, blue bars) is compared terms of all
predicted P. falciparum proteins (5410, green bars). The y-axis displays the fraction relative to all GO Molecular Function terms. These terms do not
show a significant enrichment (p.0.5).
doi:10.1371/journal.ppat.1000195.g002
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genes (Group I), 2 SGS specific genes (Group II) and 3 from
Group III (shared ODS/SGS). The sequences of the eight P.
berghei gene orthologs (as well as their corresponding up and
downstream sequences) were retrieved from the on-line Plasmo-
dium genome databases, http://www.plasmodb.org and http://
www.genedb.org/genedb/pberghei. However, for 4 of the 8
genes the P. berghei orthologs were fragmented and complete
genes were manually assembled from a number of different P.
berghei sequences by performing BLAST sequence searches of the
full length P. falciparum genes against the P. berghei genome and
closing gaps by PCR; details of the P. berghei orthologs, assemblies
and generation of knock-out constructs is available in Figure S3
and Table S5. The generation of mutant parasites was
performed in the GFP-expressing reference line of P. berghei
(i.e. line 507cl1) by standard genetic transfection of constructs for
gene-disruption by double cross-over homologous recombination
[47]. Genotype analysis of mutant parasites by Southern analysis
of genomic DNA and diagnostic PCR was performed using well
established methods [48] and details of these analyses are shown
in Figure S3.
It was not possible to select mutant parasites for two genes, one
belonging to Group I (orthologous to PF14_0607) and the other
belonging to Group III (orthologous to PFA0205w) in 3
independent transfection experiments, suggesting that both these
proteins may have an additional and essential role during blood
stage development. For the remaining 6 genes mutants were
generated in two independent transfection experiments per gene
(Table 4) and correct disruption of the target genes was shown for
all mutants (Figure S3). All 6 mutant lines showed normal asexual
growth and also gametocyte and ookinete production that was
comparable to wild type parasites (data not shown). As an initial
phenotype screen of mosquito stage development, uncloned
parental populations of the 6 mutant lines were allowed to infect
mosquitoes. Oocyst numbers and salivary gland sporozoite
numbers were determined at day 6 and 20 after infection,
respectively, and infected mosquitoes were allowed to feed at day
20–22 on naı¨ve mice. In 3 out of the 6 mutant lines (orthologous to
DPF11_0528, DPF14_0074 and DPFF1195c) parasite develop-
ment inside the mosquito (oocyst number and salivary gland
sporozoites number) was not significantly different from wild type
Table 1. Characterized proteins involved in sporozoite development and invasion of host cells.
Accession nr protein name (1) protein involved in (2)
nr unique pept/protein in life cycle stages
(3) Reference
ASX GCT GAM OOC ODS SGS
PF14_0067 CCp3 sporozoite development - 31 10 - - - Claudianos [72], Pradel [73]
PF14_0532 CCp2 sporozoite development - 39 20 - - - Pradel [73]
PFC0180c IMC1 sporozoite development (cell shape) - - - 0 9 25 Khater [74]
PFC0210c CS sporozoite development, salivary gland
and hepatocyte invasion
- - - 2 5 9 Menard [43], Wang [44]
PFB0325c cysteine protease egress from oocyst - - - - 16 23 Aly [56]
PF13_0233 myosin A sporozoite gliding motility - - - 2 39 49 Bergman [75]
PFL2225w MTIP sporozoite gliding motility 1 1 - 2 4 3 Bergman [75]
PF13_0201 SSP2/TRAP sporozoite gliding motility, salivary gland
and hepatocyte invasion
- - - 1 6 35 Rogers [45], Sultan [46]
PFI0550w CRMP1 salivary gland invasion - 1 - - - - Thompson [76]
MAL7P1.92 CRMP2 salivary gland invasion - - - - - - Thompson [76]
PF11_0486 MAEBL salivary gland invasion - - - - 33 1 Kariu [42]
MAL13P1.212 SPECT1 cell traversal hepatocytes 1 - - - - 16 Ishino [77]
PFD0430c SPECT2 cell traversal hepatocytes 1 - - - - 26 Ishino [78]
PFL0800c CelTOS cell traversal hepatocytes - - - - - 6 Kariu [79]
PFF1420w PL cell traversal hepatocytes - - - - - - Bhanot [80]
PF11_0344 AMA-1 hepatocyte invasion 1 - - - 2 19 Silvie [81]
PFB0570w SPATR hepatocyte invasion - - - - - 5 Chattopadhyay [82]
PFB0095c PfEMP3 hepatocyte invasion 3 - - - - - Gru¨ner [83]
PF07_0006 STARP hepatocyte invasion - - - - - - Pasquetto [84]
GI:1477963 SALSA hepatocyte invasion - - - - - - Puentes [85]
PFA0200w TRSP hepatocyte invasion - - - - 1 3 Labaeid [86]
PFD0215c pf52 protein/P36p hepatocyte invasion - development - - - - - 5 Ishino [29], van Dijk [30]
PFD0210c pbs36 homologue/P36 hepatocyte invasion - development - - - - - 8 Ishino [29]
1CCP (members of the LCCL protein family), IMC (inner membrane complex), CS (circumsporozoite), MTIP (myosin A tail domain interacting protein), SSP2 (sporozoite
surface protein), TRAP (Thrombospondin related anonymous protein), CRMP (cysteine repeat modular protein), MAEBL (membrane antigen erythrocyte binding like
protein ), SPECT (sporozoite microneme protein essential for cell traversal ), CelTOS (cell-traversal protein for ookinetes and sporozoites), PL (phosphoplipase), AMA
(apical membrane antigen), SPATR (secreted protein with altered thrombospondin domain), EMP (erythrocyte membrane protein), STARP (sporozoite threonine and
asparagine-rich protein), SALSA (sporozoite and liver stage antigen); TRSP (thrombospondin related protein).
2The role of these proteins has been determined by functional analysis in gene-knockout and/or antibody-inhibition studies.
3ASX - asexual blood stages; GCT – gametocytes; GAM – gametes; OOC – oocysts; ODS - oocyst-derived sporozoites; SGS - salivary gland sporozoites.
doi:10.1371/journal.ppat.1000195.t001
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parasites (Table 4). After infection of mice by bite of mosquitoes
infected with any of these three mutant lines, all mice developed
parasitemias between 0.1 and 0.5 at day 4 after infection,
indicating ‘wild type’ infectivity of the sporozoites of these 3
mutants. Genotype characterization by Field Inverse Gel Electro-
phoresis (FIGE) analysis and diagnostic PCR of blood stage
parasites after mosquito transmission of these 3 mutants revealed
the correct gene disruption genotype in blood stages of all 3
mutants, demonstrating normal mosquito transmission of the
mutant, rather than breakthrough of wild type parasites (Figure
S3). The lack of a clear effect of disruption of these 3 genes on
sporozoite production and infectivity to the mammalian host
suggests the existence of significant redundancy in the function of
these mosquito stage specific proteins.
The remaining 3 mutant lines (orthologous to DPF14_0435,
DPFD0425w and DMAL8P1.66) showed an aberrant develop-
ment during mosquito development. The phenotypes of cloned
lines of these mutants were therefore analyzed in more detail.
Clones of all 3 gene-disrupted lines produced wild type numbers of
oocysts ranging from 150–250 oocysts per mosquito on day7/8
post infection. The development of parasites deficient in
PB000829.02.0 (orthologue of PF14_0435; line 802cl1) was
blocked at the developing oocyst stage and no sporozoite
formation was detectable within the oocysts by either fluorescence
or phase-contrast microscopy (Figure 3). This early function in
sporozoite development of this protein is in agreement with its
presence in ODS and absence in SGS. The development of
parasites deficient in PB000251.01.0 (orthologue of PFD0425w;
line 841cl1) was normal up to the formation of mature oocysts
which contain sporozoite numbers similar to wild type oocysts
(Figure 3). However, only very few sporozoites were observed in
the hemocoel and salivary glands (ranging from 0–625 per
mosquito in different experiments (Figure 3)), suggesting that
egress of sporozoites from mature oocysts is severely affected. This
is also apparent from the accumulation of sporozoites in oocysts
from day 20 post infection, where higher levels of oocyst-
sporozoites were counted compared to wild type. Furthermore,
day 24–27 infected mosquitoes containing mature oocysts with
sporozoites were unable to infect mice in standard feeding
experiments (2 experiments; 2 mice per experiment). However,
when sporozoites were collected from oocysts by liberating them
using mechanical rupture and these were used to infect mice by
intravenous injection (1–26106 sporozoites) they were infective to
mice comparable to wild type ODS (2 experiments each with 2
mice). Additionally, if such oocyst-extracted sporozoites were used
in in vitro hepatocyte invasion assays they showed hepatocyte
traversal and invasion that was not significantly lower than
sporozoites from wild type sporozoites also mechanically extracted
from oocysts (Figure 3). The ‘wild type’ infectivity of oocyst-
liberated sporozoites to the mammalian host strongly indicates
that normal and viable sporozoites are formed within the oocysts
and that the absence of protein PB000251.01.0 prevents the
release of these sporozoites from the oocyst. Finally, the
development of parasites lacking PB402680.00.0 (orthologous to
MAL8P1.66; line 843cl1) was largely blocked at the oocyst stage.
However, low numbers of sporozoites were formed that were able
to invade the salivary gland (2750–6250 oocyst sporozoites per
mosquito and 875–6600 SGS per salivary gland). Despite the low
numbers of sporozoites that emerge from the oocyst, salivary gland
invasion appears not to be affected since ODS and SGS numbers
were comparable. In contrast to sporozoites of mutant 841cl1,
salivary gland sporozoites of 843cl1 injected either intravenously
(16104 sporozoites) or by mosquito bite were not infective for mice
(2 experiments with 2 mice). Interestingly, 843cl1 sporozoites
demonstrated the same or greater hepatocyte traversal rate than
wild type sporozoites and they were also able to traverse and
invade hepatocytes in vitro (Figure 3). This suggests that the lack of
sporozoite infectivity to mice may be due to a defect in liver stage
development after invasion of the hepatocyte.
Discussion
The proteome analyses of the three mosquito stages of
Plasmodium falciparum, oocysts, oocyst-derived sporozoites and
salivary gland sporozoites, resulted in the identification of 728
proteins of which 250 are ‘mosquito stage specific’, having not
been detected in our previous analysis of blood stage parasites
[15]. Although the total number of proteins identified in the
mosquito stages is lower compared to blood stages [15], which is in
all likelihood due to sample purity and not reduced protein
expression, we show a clear developmental progression of the
Table 2. Expression of Plasmodium proteins containing thrombospondin type 1 (TSP1) and/or von Willebrand factor A (vWA)
domains in different life cycle stage proteomes.
Accession nr Protein name domain nr unique pept/prot in life cycle stages (1) Reference
1 2 ASX GCT GAM OOC ODS SGS
PF13_0201 TRAP TSP1 VWA - - - 1 6 35 Rogers [45], Sultan [46]
PFC0210c CS TSP1 - - - 2 5 9 Menard [43], Wang [44]
PFA0200w TRSP TSP1 - - - - 1 3 Kaiser [18], Labaeid [86]
MAL8P1.45 hypothetical protein TSP1 - - - - 1 - Aravind [38]
PFB0570w SPATR TSP1 5 Chattopadhyay [82]
PFF0800w TRAP-like protein TSP1 VWA - 1 - - - 2 Moreira [87]
PFL0870w PTRAMP TSP1 - - - - - 1 Thompson [76]
PF10_0281 MTRAP TSP1 - - - - - - Baker [88]
PF08_0136b WARP TSP1 - - - - - - Yuda [89]
PFC0640w CTRP TSP1 VWA 1 2 - - - - Baker [88]
PFL0875w hypothetical protein TSP1 - - - - - - Aravind [38]
1ASX - asexual blood stages; GCT – gametocytes; GAM – gametes; OOC – oocysts; ODS - oocyst-derived sporozoites; SGS - salivary gland sporozoites.
doi:10.1371/journal.ppat.1000195.t002
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parasite through the mosquito that is reflected in changes of its
protein repertoire.
Analysis of the ‘stage specificity’ of proteins in six different life
cycle (mammalian and mosquito) stage proteomes demonstrated
that expression of proteins restricted to a single stage ranges from
12 to 28% with the highest percentage of ‘stage specificity’ in the
gametocyte and reaching 24% in ODS. The 478 proteins
common to blood and mosquito stages are significantly enriched
in house keeping proteins involved in metabolic processes. The
absence of specific enrichment of GO annotations in the 250
proteins of the mosquito stage specific proteome can most likely be
ascribed to the fact that a relatively small number of these proteins
posses a GO designation. Many of the mosquito stage specific
proteins are still annotated as hypothetical and probably have
functions that are specific for sporozoites and/or Plasmodium. This
concept is supported by the observation that 15 of the 23
Plasmodium proteins known to have a sporozoite specific function
are present in the 250 mosquito stage proteins identified in this
study, a 4–5 fold enrichment. Moreover, their stage specific
expression in our different proteomes also confirms that in general
the timing of protein expression coincides with observation of
function as inferred from gene deletion studies. For example,
proteins involved in the traversal and invasion of the hepatocyte
(e.g. SPECT1/2, CelTOS, AMA-1, STARP, TRSP, Pf36p and
P36 (Table 1)) are either exclusively or much more highly
expressed in SGS than ODS. Such changes in protein composition
and abundance demonstrate that sporozoites go through dynamic
changes and may exist as clearly defined developmental stages –
currently ODS and SGS – that express stage specific proteins.
These clear differences seem unexpected in the light of the
morphological similarity of the two stages but on the other hand
are in good agreement with the significant rise in mammalian host
infectivity observed during the maturation and migration of
sporozoites from oocysts to salivary glands [20,39]. These changes
are not only restricted to proteins directly involved in these
processes, but extend also to enzymes implicated in metabolic
housekeeping processes such as glycolysis, production of NADPH
and the TCA cycle that might be expected to coincide with
subcellular reorganisation at the level of the organelles. Mature,
salivary gland sporozoites might be considered to be in the resting
phase (G0) of the cell cycle and are able to persist and remain
infectious within the salivary glands of the mosquito for the
remainder of its life. Therefore, the abundance and storage of
these proteins may suggest that the salivary gland sporozoite
contains stockpiles of proteins which are deployed only upon
activation in the vertebrate host and growth (G1) and multiplica-
tion (S, M phases) inside the hepatocyte. Alternatively, some of
these proteins could specifically be required by the parasite in the
salivary glands of the mosquito host and therefore do not depend
on activation in the vertebrate host.
Protein and gene expression studies of SGS have previously
been performed in P. falciparum [10,16] as well as for the rodent
parasites P. berghei [11,20,21] and P. yoelii [18,19]. The relatively
low overlap between the proteins detected in the various
proteomes of sporozoites can in part be ascribed to the difficulties
in collecting material of sufficient purity and quantity. This
limitation results in the frequent sequencing of peptides derived
from mosquito proteins which reduces the total number of
identified parasite proteins. However, both the degree of overlap
between the proteomes and the degree of certainty in protein
calling can be improved if more strict selection criteria are used for
protein calling [31]. When we compared only proteins that were
identified by at least 2 or more fully-tryptic peptides in all datasets
(i.e. ours, Florens [10] P. falciparum SGS and Hall [11] P. berghei
SGS) we found a greater than 50% overlap in proteins. Moreover,
in the Hall P. berghei SGS and OOC proteomes it is observed that
more than 80% of these proteins have a direct ortholog in P.
falciparum. Further, when we again only compare ‘fully tryptic
proteomes’ we find 75% of the P. berghei SGS proteins are also
Figure 3. Phenotypic characterization of P. berghei mutants
(841cl1, 843cl1, 802cl1) with disrupted genes. (A) Numbers of
oocyst-derived sporozoites and salivary gland sporozoites per mosquito
from day 14 till day 27 post mosquito infection. Scale bars in Figure 3a
indicate 50 mm. Wild type (WT) sporozoite numbers are shown in blue
bars, 841 clone (PB000251.01.0/PFD0425w) gene disruptant sporozoite
numbers in purple, 843 clone (PB402680.00.0/MAL8P1.66) gene
disruptant sporozoite numbers in yellow, and 802 clone
(PB101363.00.0-PB000829.02.0-PB105739.00.0/PF14_0435) gene disrup-
tant sporozoite numbers are shown in pale blue. (B) Oocysts and
sporozoites of the three mutant lines. Upper panel: GFP-expressing
mature oocysts at day 10 after infection. Middle panel: Representative
images (phase contrast microscopy) of mature (day 12) oocyst.
Sporozoite formation in mutant 841 (PB000251.01.0/PFD0425w) is
same as WT whereas in lines 843 (PB402680.00.0/MAL8P1.66) and 802
(PB101363.00.0-PB000829.02.0-PB105739.00.0/PF14_0435) sporozoite
development is either affected (i.e. 843) or completely absent (i.e.
802). Lower panel: GFP-expressing sporozoites (released by mechanical
rupture of oocysts at day 18–20). Scale bars in Figure 3b indicate 12 um.
(C) Hepatocyte traversal and invasion of oocyst derived sporozoites
(841, PB000251.01.0/PFD0425w)) and salivary gland sporozoites (843,
(PB402680.00.0/MAL8P1.66)) compared to WT sporozoites similarly
mechanically liberated from oocyst. Bars represent the average
percentage of HepG2 cell traversal and invasion relative to wild type.
Scale bars in Figure 3c indicate 12 um.
doi:10.1371/journal.ppat.1000195.g003
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expressed in the SGS of P. falciparum indicating that sporozoites of
different Plasmodium species employ similar processes of maturation
and invasion. Despite the relatively low overlap in total numbers of
proteins detected in the different proteomes, there is good
correlation of protein abundance between our SGS proteome
and the previously reported SGS proteome of P. falciparum [10]
based on peptide counting methods.
Interestingly, nearly all the expressed genes of P. yoelii
sporozoites detected by EST analyses [18] are also present in
our proteome. Similarly, in a recent microarray analysis of P. yoelii,
where 5500 expressed genes were measured in the ODS/SGS
stages we find that all of our 601 (i.e. 601 of the 728 P. falciparum
genes that have a P. yoelii ortholog) mosquito stage specific P.
falciparum proteins are also detected as mRNA [22].
We found a lower percentage of shared proteins between our
proteome and the transcripts detected in sporozoites of P. berghei
[11,20,21]. The variation in overlap between the various proteome
and transcriptome studies is certainly influenced by the varying
and often small number of identified genes/proteins and indicates
that a comprehensive expression profile of the salivary gland
sporozoite has still to be realized. Comparison of mRNA species
detected in P. falciparum SGS [22] with our proteome showed that
for a large percentage of genes, mRNA production coincides with
the presence of its protein (463 mRNA species for 477 proteins;
97%). The simultaneous presence of transcripts and protein
expression has also been observed during blood stage develop-
ment, supporting the ‘just in time’ model [9]. However, more than
2100 genes demonstrate an up-regulation of transcription in
sporozoites [22], many of which were not detected as a protein in
the various proteome studies. Moreover, a low correlation exists
between the abundance levels of our SGS proteins (i.e. by emPAI)
and the mRNA abundance of previously reported large-scale SGS
transcriptome studies (i.e. r = 0.31–0.33; [16,22]). This is in line
with the observations made by Le Roch et al (2004) where
transcript levels are not always well correlated with same stage
protein expression, suggesting a delay between mRNA and protein
accumulation [49]. It is interesting to speculate whether these
differences in expression between RNA and protein could be in
part explained by translation repression as is observed in
gametocytes that contain pools of translationally repressed
transcripts that are only translated following zygote formation
[11,50,51]. However, as discussed above, the proteome of
sporozoites may not be comprehensive enough to draw conclu-
sions about the relationship between specific mRNA and protein
expression patterns.
The sporozoite proteomes, despite not being exhaustive,
provide for the first time information on parasite protein
expression both at the mosquito midgut and salivary gland stages.
This has allowed for the identification of hitherto uncharacterized
proteins which in turn has informed the selection of genes for
targeted orthologous gene disruption studies in the rodent malaria
parasite, P. berghei. Mutant P. berghei parasites lacking mosquito
stage specific proteins have proven to be an efficient way to obtain
an understanding into the function of such proteins [52]. We were
able to generate 6 mutants for 8 hypothetical proteins that were
selected from our proteomes for further functional analysis in P.
berghei of which 3 showed distinct phenotypes, demonstrating an
important and essential role of these proteins in sporozoite
development and maturation. The knock-out parasite lines of 3
genes that do not exhibit a clear phenotypic difference from wild
type parasites indicate either a redundancy in function for the
proteins encoded by these genes or else phenotypes that are
presently too subtle for us to detect with our current methodol-
ogies. However, functional redundancy is a well-established
phenomenon for a number of Plasmodium proteins that are
expressed in the blood and sexual stages of the parasite [53–55].
The P. falciparum protein PF14_0435 is highly and exclusively
expressed in sporozoites obtained from the oocyst stage and the
phenotype of the orthologous gene knock-out mutant in P. berghei,
802cl1, is an abnormal development of the oocyst and the
complete absence of sporozoite production. This example
demonstrates not only the validity of the orthologous gene studies
in P. berghei but also the informative power of this combination of
proteome-reverse genetic approach in the characterization of
proteins at discreet stages of the parasite life-cycle. Furthermore,
the number of oocysts produced by the 802cl1 mutant is not
different from wild type levels and a defect appears to occur prior
to sporozoite development indicating that the role of PF14_0435 is
upstream of sporozoite production. The phenotype of a second P.
berghei mutant, line 841cl1, which lacks the orthologue of
PFD0425w closely resembles the egress defects observed with
the cysteine protease ECP1 (or SERA8 in P. falciparum) and CS
mutants that are mutated in their thrombospondin repeat; where
sporozoites are unable to exit from midgut oocysts [44,56].
Although ECP1 mutant sporozoites are not infectious, it has been
suggested that ECP1 may be involved in the cleavage of CS and
thereby release of sporozoites from the oocyst [4]. Interestingly,
while oocyst-derived sporozoites that lack ECP1 or express
mutated CS are not infective to mice, the mechanically liberated
oocyst-derived sporozoites of mutants lacking PFD0425w are able
to establish an infection in mice by i.v. inoculation, and this implies
that PFD0425w - in contrast to ECP1 - has no additional function
during infection of the mammalian host. Its role appears to be
restricted and directly involved in sporozoite release from the
oocyst and has a more immediate/causative function in the release
of sporozoites from oocysts. In contrast, the protein MAL8P1.66
appears to have multiple roles during sporozoite development
within the oocyst and infectivity to the mammalian host. Mutants
lacking this protein (i.e. line 843) are affected in the production of
sporozoites within oocysts. However, the low numbers of
sporozoites formed are able to invade salivary glands and
hepatocytes in vitro but are unable to infect mice, suggesting an
additional role during further development inside the hepatocyte.
Interestingly and in line with the expectation, the expression of
MAL8P1.66 has recently been identified in liver stage of
Plasmodium [57]. The exact role during development of the liver
stages awaits further analysis.
This study sheds light not only on the development and
maturation of the malaria parasite in an Anopheles mosquito but
also identifies proteins that are uniquely synthesized as the
sporozoite becomes increasingly infectious to humans. Infection
initiated by injection of P. falciparum sporozoites into humans
represents the culmination of many precise, sequential and critical
developmental steps of the malaria parasite through the mosquito.
Moreover, transmission is a bottle neck in the life cycle of
Plasmodium and the full maturation of sporozoites is essential in the
survival of the parasite. The changes in the different sporozoite
proteomes documented here emphasise that each event from
oocyst development to egress and invasion of salivary gland and
injection is tightly regulated. Intervention studies are now being
conducted that aim to exploit the tightly regulated pathways that
the parasite has evolved to ensure transmission. This has been
recently demonstrated with the use of genetically attenuated
sporozoites that have rapidly become an important focus in the
development of new vaccines. The disruptions of individual genes
that encode sporozoite proteins sufficiently weakens the parasite
such that development in the liver is blocked, enabling the
mammalian host to generate a strong protective immunity against
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subsequent infection. Clearly, the targeted disruption of genes
encoding proteins identified in this study, which are involved in
essential mature sporozoites functions, namely hepatocyte travers-
al, invasion and intracellular survival may also accelerate the
identification of new protective attenuated parasite lines. Under-
standing the sporozoite and all its various developmental steps
during the establishment of an infection continues to represent a
promising approach in the hunt for new weapons in the fight
against malaria.
Materials and Methods
Collection of P. falciparum oocysts and sporozoites
Anopheles stephensi mosquitoes (Sind-Kasur strain, 3–5 days old)
[58] were infected with P. falciparum gametocytes (NF54) [59] by
membrane feeding. Unfed and partially fed mosquitoes were
removed and fully fed mosquitoes were kept at 2661uC at 80%
humidity. After one day, a 5% glucose solution soaked in cotton
wool was offered to the mosquitoes and mosquitoes were allowed
to take an extra (uninfected) blood meal at day 8–10 after infection
[60]. Oocysts and oocyst-derived sporozoites were collected from
midguts at 7–8 and 13–14 days after infection, respectively.
Approximately 100–200 mosquito midguts were hand-dissected
and homogenized in a home made glass tissue grinder in 200 ml of
PBS pH 7.2 at 4uC. Salivary gland sporozoites were collected from
salivary glands 18–22 days after infection. Approximately 70
salivary glands were hand-dissected and treated in a similar way as
the oocyst samples. For the parasite preparations (OOC, ODS and
SGS), four, three and two batches respectively were generated and
processed further for analysis by nLC-MS/MS.
Sample preparation for Mass Spectrometry analysis
In order to estimate the number of sporozoites in the samples
described above the total number of oocyst and salivary gland
sporozoites per mosquito was determined as follows: midguts and
salivary glands were dissected from 10 mosquitoes at day 13 and
day 22 after feeding respectively. The midguts/salivary glands
were homogenized in a home made glass grinder in 1000 ml of
PBS pH 7.2 and sporozoites were counted in a Bu¨rker-Tu¨rk
counting chamber using phase-contrast microscopy (1–1.66105
sporozoites obtained from salivary glands of one mosquito, and
0.5–56105 sporozoites per mosquito midgut). Parasites samples
from mosquito midguts and salivary glands (approx. 1–46107
ODS and SGS sporozoites, and 1–26104 oocysts from 65–200
mosquito midguts) were divided into a soluble and insoluble
fraction by a freeze–thawing procedure similar to the parasite
sample preparation procedure of blood stages [15]. Complex
protein mixtures of both fractions derived from different batches
were extracted in SDS–polyacrylamide gel electrophoresis (PAGE)
loading buffer and subsequently separated into 10 or 22 fractions
per sample batch after electrophoresis on a 10% protein gel to
reduce protein complexity, allowing protein identification by 1D
LC-MS/MS. Because parasite samples were contaminated with
mosquito host proteins (from midguts and salivary glands), we also
analysed an increased number of gel slices (22 slices per gel)
compared to 10 slices used in our previous analysis for P. falciparum
blood stages. Gel slices were treated with dithiothreitol and
iodoacetamide and digested by trypsin as described before [15].
Nano–liquid chromatography tandem mass
spectrometry
The nLC-MS/MS procedure as described for the analysis of
blood stages [15] was used with minor adjustments. Peptide
mixtures were loaded onto 100 mm ID columns packed with 3 mm
C18 particles (Vydac) and eluted into a quadruple time-of-flight
mass spectrometer (QSTAR, Sciex-Applied Biosystems). Fragment
ion spectra were recorded using information-dependent acquisi-
tion and duty-cycle enhancement. Since the parasite samples were
contaminated with host (mosquito) proteins, we measured samples
up to four times with exclusion lists to acquire MS/MS spectra of
P. falciparum peptides. Peptides sequenced in the first run were
excluded for sequencing in subsequent runs, peptides from the 2nd
run were excluded in the 3rd run etc. This procedure results in an
enrichment of low abundant peptides in the second, third and
fourth LC-MS/MS run. In total, more than 750 LC-MS/MS runs
were acquired resulting in at least 200,000 MS/MS spectra per
parasite stage. Plasmodium proteins were identified by searching
combined protein databases of P. falciparum (http://www.
plasmodb.org), Anopheles gambiae (ftp://ftp.ensembl.org/pub/) and
human IPI (ftp://ftp.ebi.ac.uk/pub/databases/IPI/) using the
Mascot search algorithm (Matrix Science) with tryptic require-
ment and 0.2 Da mass tolerance for precursor mass and fragment
masses. First ranked peptides (Mascot peptide scores.15) were
parsed from Mascot database search html-files with MSQuant
(http://www.msquant.sourceforge.net) to generate unique first
ranked peptide lists. Plasmodium proteins identified by 1–3 three
first ranked peptides were verified by manual inspection of the
MS/MS spectra in MSQuant or in Mascot. An initial validation
filter was applied to the dataset after reversed database searches. A
minimal Mascot peptide score of 30 was determined by a reverse
database search, which revealed a false positive rate of 17% for
proteins identified by 1 peptide with a Mascot peptide score.30,
delta score.5), 5% for proteins identified by 2 peptides (average
Mascot score.30) and 0.3% for proteins identified by more than 2
peptides. Manual verification for proteins detected by less than 4
peptides substantially decreased the false positive rates and
included proteins below this filter. After internal calibration of
the peptide masses by MSQuant, an average absolute mass
accuracy of 23.5 ppm was obtained for the entire dataset of P.
falciparum peptides. To remove redundancy on the protein level
and to uniquely assign peptides to one protein, the peptides were
remapped to PlasmoDB 5.3 annotated genome using the program
Protein Coverage Summarizer (http://ncrr.pnl.gov/software/).
The collected peptide list of this study (malaria peptides identified
in the mosquito stages) is available in Table S1.
Identified peptide count analysis to determine protein
abundance index values
To determine the protein abundance in our samples, mass
spectrometric data was analyzed using an identified peptide per
protein count analysis to compute the exponentially modified
Protein Abundance Index (emPAI) values [16,22]. EmPAI values
for all proteins in Table S1 were calculated as 10PAI–1
(PAI = nobserved peptides/nobservable peptides). The number of ‘observ-
able’ peptides per protein was calculated from the output of the
program Protein Digestion Simulator (http://ncrr.pnl.gov/
software/), which computes peptide masses and hydrophobicities
of simulated digests of protein databases. Two approaches were
chosen to merge data from proteins identified in several slices, runs
and batches. The first approach calculates emPAI values per slice
for collapsed data of different runs. Per sample batch, emPAI
values were subsequently summed over all slices. In cases for 22 gel
slices per lane, data of two slices were merged to create a similar
number of emPAI fractions for all samples. The second approach
calculates emPAI values for merged data of all slices of all runs per
sample batch. Both approaches resulted in protein emPAI values
in 4 OOC batches (1–26104 oocysts), 3 ODS batches (1.4–
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3.86107 sporozoites) and 2 SGS batches (1.3–2.56107 sporozo-
ites).
Normalization between different batches was performed
according to the median and 20 percent trimmed mean method
[61]. Normalization methods and approaches for merging emPAI
data were evaluated on performance in correlation studies with
mRNA data of P.falciparum salivary gland sporozoites [16,22]
(Table S3). Mean protein emPAI values of merged and median
normalized data were calculated per stage and have been included
in Table S1. This approach was also applied to our proteomic data
set of blood stages [15] to calculate normalized emPAI values.
Correlation between protein expression data from
different studies
Values for the level (abundance) of protein expression from
different datasets were obtained for all individual proteins by
calculated emPAI values. EmPAI values and mRNA levels of
microarray analyses were log2 transformed before regression
analysis to obtain normal distributions. Pearson correlation
between datasets was performed using R (http://www.r-project.
org/).
Gene ontology annotation
Gene Ontology SLIM terms were assigned using ‘‘Generic GO
(http://go.princeton.edu/cgi-bin/GOTermMapper). A GO en-
richment analysis for ‘Biological Process’, ‘Cellular Component’
and ‘Molecular Function’ using default GO association files was
performed with ‘‘GO Term Finder’’ (http://go.princeton.edu/cgi-
bin/GOTermFinder) where statistical significance (p-value) is
calculated based on hypergeometric distribution with Bonferroni
multiple testing correction and false discovery rate calculation as
described [62]. To perform a GO enrichment analysis with
adjusted GO association files, Ontologizer (http://www.charite.
de/ch/medgen/ontologizer/) was used where statistical signifi-
cance (p-value) is calculated as in ‘GO Term Finder’(see above
and [63]).
Selection criteria for ODS, SGS and ODS/SGS proteins
Proteins with more than 90 percent of the peptides detected in
the mosquito stages (mosquito fraction.0.9) were divided into
three groups (OOC, ODS and ODS/SGS) based on their
expression patterns. The mosquito fraction equals nmosq/(nmosq+
nblood) where n is the number of unique peptides per protein at the
mosquito and blood stages, respectively. The mosquito enriched
proteins were further subdivided into 112 ODS-specific proteins
expressed in the ODS stage and not SGS (Group I); 74 SGS-
specific proteins not expressed in ODS (Group II); and finally 59
Group III proteins that are shared between several mosquito life
cycle stages. A further refinement of these groups was based on the
following criteria. Only proteins with more than two peptides
detected in the mosquito stages (nmosq$3) were considered. In
addition, only proteins were selected that contained Signal peptide
(SP), Transmembrane (TM) or Glycosylphosphatidylinositol (GPI)
domains and combinations of these motifs. Sequence–based
prediction data for these domains was retrieved from PlasmoDB
(http://www.plasmodb.org) for SP and TM domain predictions
based on TMHMM, TMAP, TMHMM2 and TOPRED2
algorithms; from http://gpi.unibe.ch/ for GPI predictions by a
Kohonen Self Organizing Map; and from http://smart.embl-
heidelberg.de/ for SMART protein domain searches. The
number of TM domains is the average of four values obtained
from the different TM prediction algorithms. Different criterions
were set for combinations of predicted motifs. For less abundant
proteins without predicted signal peptide (SP = 0, and
3#nmosq#15), only proteins with at least 4 predicted TM regions
were included (average TM.4). For abundant proteins without
signal peptide (SP = 0, nmosq.15) proteins with at least 0.5
predicted TM regions (average TM$0.5) were included. For
proteins with predicted signal peptide (SP = 1), all proteins with at
least 0.5 predicted TM regions (average TM$0.5) were included.
Finally, all proteins with a predicted GPI anchor (GPI = 1) were
selected independent of the presence of predicted signal peptide or
TM regions.
Generation and characterization of gene knockout P.
berghei parasite mutants
Eight P. falciparum proteins were selected for functional analysis
by targeted gene disruption of their corresponding orthologs in P.
berghei. The sequences of the eight P. berghei gene orthologs (as well
their corresponding up and downstream sequences) were retrieved
from the on-line Plasmodium genome databases, http://www.
plasmodb.org and http://www.genedb.genedb/genedb/pberghei .
For P. berghei genes with incomplete sequence information in the
database (4 out of 8), the complete genes were manually assembled
from a number of different P. berghei sequences by performing
BLAST sequence searches of the full length P. falciparum genes
against the P. berghei genome and closing gaps by PCR and DNA
sequencing (see for details Figure S3 and Table S5). Standard
plasmid vectors were designed for targeted gene disruption by
double cross-over homologous recombination [48]. To replace the
protein coding sequences of the target genes with the dhfr/ts
pyrimethamine resistance marker from Toxoplasma gondii, we cloned
the 59 and 39 flanking regions of the gene of interest up- and
downstream of the selection cassette of pl0001; also in MR4 (http://
www.mr4.org/). Briefly described for one candidate gene, to
generate a PB000829.02.0/PF14_0435 disruption vector, an
upstream region (position 74–436 on singleton berg-2274h02.p1k)
and a downstream region (position 516–1016 on contig PB_RP2658)
- the latter containing the P. berghei orthologous gene
PB000829.02.0 - were amplified from P. berghei genomic DNA using
primer-pairs 2666–2653 and 2654–2655, respectively. The PCR
products were digested with Asp718 and HindIII, or EcoRI and NotI,
respectively, and ligated into plasmid pl0001 yielding targeting
plasmid pL1175 (see for further details of all plasmids and the
sequence of the primers, Figure S3 and Table S5). All plasmids
generated were sequence analysed. Transfection of GFP-expressing
‘wild type’ parasites from the P. berghei reference line 507cl1 [64] with
linearised targeting constructs, selection and cloning of the mutant
parasites were performed according to procedures previously
described [48]. Genotypic analysis of transfected parasites was
performed by Southern analysis of FIGE separated chromosomes
and diagnostic PCR on genomic DNA (details of the primers used
for PCR are shown in Table S5).
Phenotype analysis of mutant parasites during blood stage
development, quantification of gametocyte production and
ookinete development in vitro was performed using standard
methods as previously described [14,65]. Mosquito stage devel-
opment was analysed in A. stephensi mosquitoes using standard
methods of infection of mosquitoes and analysis of oocyst and
sporozoite production and analysis of sporozoite infectivity to
C57Bl6 mice [66]. The number of sporozoites in oocysts of
mosquito midguts and in salivary glands derived from 10
mosquitoes was determined in quadruplicate as described above
for counting P. falciparum sporozoites and represented as mean
number with standard deviation per stage per mosquito. The
capacity of the mutant parasites to infect mice by mosquito
interrupted feeding was determined by exposure of female C57Bl6
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mice (n = 2–4) to 40–50 mosquitoes, at day 20 after the infectious
blood meal. Infection was monitored by analysis of blood stage
infection in Giemsa stained films of tail blood at day 4 till day 8
after infection. Infectivity was recorded as ‘wild type’ if mice
developed a parasitemia of 0.1–0.5% at day 4 after infection.
Infectivity of sporozoites to mice of 2 mutant lines was also
determined by intravenous injection of sporozoites that were
mechanically liberated by a glass grinder from either midgut
oocysts (1–26106 oocyst sporozoites collected at day 20 from
mutant line 841 and wild type line 507cl1) or collected from
salivary glands (104 salivary gland sporozoites at day 27 for mutant
line 843 and wild type line 507cl1). For obtaining oocysts and
salivary gland sporozoites, mosquito midguts or salivary glands
were dissected in a drop of RPMI culture medium and the
transferred by a custom made needle into a glass grinder after
which sporozoites were released by gently grinding. Blood stage
infection in mice injected with sporozoites in 200 ml RPMI buffer
was monitored as described for infection of mice via mosquito
interrupted feeding.
In vitro hepatocyte traversal and invasion experiments were
performed as described elsewhere [67,68] by adding purified
sporozoites (56104) to confluent monolayers of HepG2 cells in
DMEM medium (note: medium had 10% FCS and 1% PenStrep).
Mutant sporozoites were obtained as described above from either
oocysts (day 20) or from salivary glands (day 27). Quantification of
cell traversal and invasion was accomplished by using a cell-
impermeable fluorescent marker molecule, rhodamine-dextran at
1 mg/ml that will visualize parasitized wounded cells specifically
but not uninfected HepG2 cells. Sporozoites were incubated with
HepG2 cells in the presence of fluorescent dextran for 2 hr,
followed by washing the cells to remove the marker and incubation
for an additional 24 hours to determine the development of
exoerythrocytic forms (EEFs) of the parasite. Hepatocyte invasion
was determined by counting the percentage of sporozoites inside
dextran-negative cells because parasites do not develop success-
fully in wounded dextran-positive cells [68]. After fixation of the
HepG2 cells, infection was quantified by staining EEFs with
monoclonal antibody 2E6 against HSP70 [69] and compared to
infection of wild type sporozoites. Hepatocyte cell traversal was
determined by counting the percentage of dextran-positive cells
2 hours after adding sporozoites to HepG2 cells, and compared to
wild type sporozoite cell traversal. In this procedure, monoclonal
antibody 3D11 against CS was used.
Accession Numbers
All datasets will become available through the official Web site
of the Plasmodium genome project, PlasmoDB (http://www.
plasmodb.org [70,71]). In the text and tables most genes and gene
products are accompanied with their PlasmoDB Accession
Number.
The PlasmoDB accession numbers for other genes and gene
products discussed in this paper are for P. falciparum: CS
(PFC0210c), TRAP (PF13_0201), UIS3 (PF13_0012), P36
(PFD0210c), P36p (PFD0215c), myosin A (PF13_0233), MTIP
(PFL2225w), actin (PFL2215w) and F-1,6-BP aldolase
(PF14_0425), AMA-1 (PF11_0344), TRSP (PFA0200w), RESA8
(PFB0325c), SPECT1 (MAL13P1.212), SPECT2 (PFD0430c),
CelTOS (PFL0800c), STARP (PF07_0006); and for P. berghei:
UIS4 (PB100551.00.0), ECP1 (PB000649.01.0).
The sequences of the eight P. berghei gene orthologs (as well their
corresponding up and downstream sequences) that have
been analysed in gene-disruption studies were retrieved from
the PlasmoDB database (http://www.plasmodb.org) and from
the GeneDB database (http://www.genedb.genedb/genedb/
pberghei). For 4 out of 8 P. berghei genes with incomplete sequence
information in the database, the complete genes were manually
assembled from a number of different P. berghei sequences by
performing BLAST sequence searches, PCR and DNA sequenc-
ing (see for details Figure S3 and Table S5). Primer sequences used
in contig gap closure and location of primers relating to contigs
and reads of the revised P. berghei gene models have been submitted
to GenBank and are provided in Figure S3 and Table S5.
Supporting Information
Figure S1 Gene Ontology (GO) annotation for proteins from
proteomes from two mosquito stages of P. falciparum, oocyst-
derived sporozoites and salivary gland sporozoites.
Found at: doi:10.1371/journal.ppat.1000195.s001 (0.05 MB
DOC)
Figure S2 Pathway profiling with the number of unique
peptides/protein detected in 5 different life-cycle stages (data
obtained from this study and from Lasonder et al. ([15]).
Found at: doi:10.1371/journal.ppat.1000195.s002 (0.09 MB
DOC)
Figure S3 Generation and genotype analysis of P. berghei
mutants with disrupted genes that encode orthologs of mosquito
stage proteins of P. falciparum.
Found at: doi:10.1371/journal.ppat.1000195.s003 (5.77 MB PPT)
Table S1 Peptides and proteins of P. falciparum identified in
proteomes of oocysts, oocyst-derived sporozoites and salivary
gland sporozoites. Page ‘Peptides’: peptides identified by nLC-
MS/MS. Information provided in the table: 1) life cycle stage, 2)
peptide sequence, 3) MCR (mass of charge of parent ion), 4)
charge of parent ion, 5) measured mass of peptide, 6) calibrated
mass of peptide after internal mass calibration, 7) peptide rank in
Mascot searches, 8) peptide score in Mascot searches, 9) Mascot
peptide delta score (which equals the Mascot score difference
between a rank1 and a rank2 peptide), 10) accession number of
protein identification from PlasmoDB version 5.3, 11) protein
name, 12 reannotation PlasmoDB 2008)07)15 (genes with the most
recently modified annotation by PlasmoDB), 13) protein mass
(molecular weight), 14) protein pI (iso-electric point), 15) nr
pept)prot)sample (the number of unique peptides per protein), 16)
Residue Start (residue nr in the protein sequence of the N-terminal
amino acid), 17) Residue End (residue nr in the protein sequence
of the C-terminal amino acid), 18) sequence coverage (percentage
of the protein covered by the identified peptides), and 19) protein
emPAI value. Page ‘Proteins’: The corresponding proteins
identified by the sequenced peptides, listing: 1) accession number
(PlasmoDB version 5.3), 2) protein name, 3 reannotation
PlasmoDB 2008)07)15 (genes with the most recently modified
annotation by PlasmoDB) 4) protein mass (molecular weight), 5)
protein pI (iso-electric point), 6) number of unique identified
peptides, 7) protein emPAI value, and 8) mosquito fraction (which
is calculated by the number of detected peptides in mosquito stages
divided by the sum of the number of peptides in mosquito and
blood stages). Page ‘OOC’: proteins detected in OOC; column
headings the same as for Page ‘Proteins’. Page ‘ODS’: proteins
detected in ODS; column headings the same as for Page ‘Proteins’.
Page ‘SGS’: proteins detected in SGS; column headings the same
as for Page ‘Proteins’. Page ‘Mosquito stage specific’: proteins
exclusively detected in mosquito stages (mosquito fraction = 1);
column headings the same as for Page ‘Proteins’. Page ‘Shared
with RBC stages’: proteins detected in mosquito stages and blood
stages (0,mosquito fraction,1); column headings the same as for
Page ‘Proteins’. Page ‘OOC-enriched’: proteins that are ‘highly
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enriched’ in OOC (mosquito fraction.0.9); column headings the
same as for Page ‘Proteins’. Page ‘ODS-enriched’: proteins that
are ‘highly enriched’ in ODS (mosquito fraction.0.9); column
headings the same as for Page ‘Proteins’. Page ‘SGS-enriched’:
proteins that are ‘highly enriched’ in SGS (mosquito frac-
tion.0.9); column headings the same as for Page ‘Proteins’. Page
‘tRNA ligase’: overview of all tRNA proteins detected in mosquito
stages, column headings the same as for Page ‘Proteins’.
Found at: doi:10.1371/journal.ppat.1000195.s004 (3.44 MB ZIP)
Table S2 Comparison of proteins identified in the mosquito
stage proteomes of this study with the proteomes of salivary gland
sporozoites (SGS) of P. falciparum as reported by Florens and
colleagues [10] and the proteomes of oocysts (OOC) and SGS of
P. berghei as reported by Hall and coworkers [11]. The tables
contain information about proteins shared by our analysis and
others, where our expression data is presented by the number of
unique tryptic peptides per protein. The other data sets are
presented in a similar way, but a distinction is made in expression
data for detection either by all peptides (tryptic, half (non) tryptic),
or by tryptic peptides.
Found at: doi:10.1371/journal.ppat.1000195.s005 (1.58 MB ZIP)
Table S3 Correlation of protein abundance (emPAI approach)
identified in the SGS stage proteome of this study with mRNA
levels of the SGS transcriptomes of P. falciparum as reported by Le
Roch and coworkers [16] and Zhou and coworkers [22]. Tables
show Pearson correlation coefficients (r), probabilities (p) and
number of shared genes/proteins (n).
Found at: doi:10.1371/journal.ppat.1000195.s006 (0.02 MB XLS)
Table S4 Comparison of proteins identified in the mosquito
stage proteomes with genes transcribed in sporozoites in P. berghei
and P. yoelii as identified by either subtractive hybridization (SSH)
or cDNA quantification methods (SAGE). S-genes: 25 sporozoite (S)
genes identified in a P.yoelii SSH screen [18]. UIS-genes: 30 UIS
genes (Upregulated In Sporozoites) identified in a P. berghei SSH
screen [20]. SIS genes: 123 SIS genes (Sporozoite expressed gene
Identified by SAGE (SIS) genes) identified in a P. berghei SAGE
analysis [21].
Found at: doi:10.1371/journal.ppat.1000195.s007 (0.06 MB XLS)
Table S5 Primer sequences used in this study. Primers used in
KO targeting plasmid construction. Primers used to check for
plasmid integration in mutant (KO) parasites. Primers used in
contig gap closure and wild type (WT) PCR analysis.
Found at: doi:10.1371/journal.ppat.1000195.s008 (0.03 MB XLS)
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